Preferred Name |
Mepivacaine |
|
Synonyms |
|
|
Definitions |
An amide-type local anesthetic agent. At the injection site, mepivacaine binds to specific voltage-gated sodium ion channels in neuronal cell membranes, which inhibits both sodium influx and membrane depolarization. This leads to a blockage of nerve impulse initiation and conduction and results in a reversible loss of sensation. Compared to other local anesthetics, this agent has a more rapid onset and moderate duration of action. |
|
ID |
http://purl.obolibrary.org/obo/NCIT_C61831 |
|
CAS_Registry |
96-88-8 |
|
CHEBI_ID |
CHEBI:6759 |
|
Chemical_Formula |
C15H22N2O |
|
code |
C61831 |
|
Contributing_Source |
FDA |
|
definition |
An amide-type local anesthetic agent. At the injection site, mepivacaine binds to specific voltage-gated sodium ion channels in neuronal cell membranes, which inhibits both sodium influx and membrane depolarization. This leads to a blockage of nerve impulse initiation and conduction and results in a reversible loss of sensation. Compared to other local anesthetics, this agent has a more rapid onset and moderate duration of action. |
|
FDA_UNII_Code |
B6E06QE59J |
|
Has_Salt_Form | ||
in_subset | ||
label |
Mepivacaine |
|
Legacy Concept Name |
Mepivacaine |
|
Preferred_Name |
Mepivacaine |
|
prefixIRI |
NCIT:C61831 |
|
prefLabel |
Mepivacaine |
|
Semantic_Type |
Pharmacologic Substance |
|
UMLS_CUI |
C0025384 |
|
subClassOf |